Los Angeles, California 90057

  • Atopic Dermatitis

Purpose:

This is a multi-center, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.


Criteria:

Inclusion Criteria: - Male and non-pregnant, non-lactating female patients aged 18 - 70 years (inclusive); - Diagnosed with atopic dermatitis; - Suffering from chronic pruritus; - Body Mass Index (BMI) of ≥18 and ≤40 kg/m2 Exclusion Criteria: - Chronic pruritus due to condition other than atopic dermatitis (AD); - A positive test for drugs of abuse at the screening or evaluation visits; - Exposure to any investigational medication in the past 60 days


NCT ID:

NCT04140695


Primary Contact:

Vanda Pharmaceuticals
Phone: 202-734-3400
Email: clinicaltrials@vandapharma.com


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90057
United States

Vanda Pharmaceuticals

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 15, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.